Journal
BIOCHEMICAL PHARMACOLOGY
Volume 202, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2022.115118
Keywords
Fibrosis; Glycolysis; Hypoxia; Melatonin; Pancreatic stellate cells
Categories
Funding
- Ministerio de Econom?a y Competitividad [BFU2016-79259-R]
- Ministerio de Ciencia, Innovacio ? [EQC2018-004646-P, EQC2019-005660-P]
- Junta de Extremadura-FEDER [GR21037]
- Valhondo Calaff Foundation
Ask authors/readers for more resources
Pancreatic stellate cells (PSCs) proliferate actively under hypoxia and melatonin has been shown to modulate cell responses to hypoxia by inhibiting proliferation and reducing fibrosis-related protein expression. The activation of the PI3K/Akt/mTOR pathway and metabolic adaptations in PSCs under hypoxic conditions were investigated in this study. The results suggest that PSCs undergo metabolic changes under hypoxia and melatonin plays a role in modulating these changes.
Pancreatic stellate cells (PSCs), the main cell type responsible for the development of fibrosis in pancreatic cancer, proliferate actively under hypoxia. Melatonin has received attention as a potential antifibrotic agent due to its anti-proliferative actions on PSCs. In this work, we investigated the activation of the PI3K/Akt/mTOR pathway and the metabolic adaptations that PSCs undergo under hypoxic conditions, as well as the probable modulation by melatonin. Incubation of cells under hypoxia induced an increase in cell proliferation, and in the expression of alpha-smooth muscle actin and of collagen type 1. In addition, an increase in the phosphorylation of Akt was observed, whereas a decrease in the phosphorylation of PTEN and GSK-3b was noted. The phos-phorylation of mTOR and its substrate p70 S6K was decreased under hypoxia. Treatment of PSCs with melatonin under hypoxia diminished cell proliferation, the levels of alpha-smooth muscle actin and of collagen type 1, the phosphorylation of Akt and increased phosphorylation of mTOR. Mitochondrial activity decreased in PSCs under hypoxia. A glycolytic shift was observed. Melatonin further decreased mitochondrial activity. Under hypoxia, no increase in autophagic flux was noted. However, melatonin treatment induced autophagy activation. Never-theless, inhibition of this process did not induce detectable changes in the viability of cells treated with mela-tonin. We conclude that PSCs undergo metabolic adaptation under hypoxia that might help them survive and that pharmacological concentrations of melatonin modulate cell responses to hypoxia. Our results contribute to the knowledge of the mechanisms by which melatonin could modulate fibrosis within the pancreas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available